Dr. Joseph Sinkovics still stands as a live witness, who was first in the late 1960s to observe and photograph the hitherto unknown large granular lymphocytes in his own blood, which were killing allogeneic human tumor cells in vitro; and photographed both the small compact human immune T cells and the large granular NK cells of patients, as they were killing human sarcoma and melanoma cells upon encounter in vitro (Page 289 Ref [117]; Page 295 Ref [156]; Page 362 Ref [611]). He has been involved in the discovery of human lymphocytes cytolytic to human cancer cells; their increase during…mehr
Dr. Joseph Sinkovics still stands as a live witness, who was first in the late 1960s to observe and photograph the hitherto unknown large granular lymphocytes in his own blood, which were killing allogeneic human tumor cells in vitro; and photographed both the small compact human immune T cells and the large granular NK cells of patients, as they were killing human sarcoma and melanoma cells upon encounter in vitro (Page 289 Ref [117]; Page 295 Ref [156]; Page 362 Ref [611]). He has been involved in the discovery of human lymphocytes cytolytic to human cancer cells; their increase during immunotherapy with viral oncolysate vaccines; and thus leading to therapeutic infusions of autologous immune lymphocytes in the 1970s to 2006 (Page 350 Ref [530]; Page 358 Ref [582]). It occurs to him now to ask how those ligands evolved that kill immune T lymphocytes by activating their PD-1 receptors (Page 368 Ref [635]). When low-branching single-celled eukaryotes (amoeba; giardia; trichomonads; theileria) transformed from free-living animal cells to be the parasites of large multicellular hosts with highly developed immune systems (including Homo), then these organisms needed those ligands to kill immune lymphocytes of their new hosts. If so, they carry the ancestors of those genes that encode the armada of these ligands in the human genome. How the theileria convert and lyse their bovine hosts' lymphocytes (Page 369 Ref [637])! Its ancestors must have acquired genes to generate those ligands. Could anti-ligand mcab therapy applied for the treatment of parasitic infestations? How the triploblastic bilateral hosts (Homo), in their malignant cells acquired genes for those ligands: by vertical inheritance (where from?), or through lateral (horizontal) gene transfers from ancient parasites (Page 365 Ref [619]; Page 367 Ref [629,630]; Page 369 Ref [637]). There should be a short time allowed for Sinkovics to speculate about that!Thank you.
Sinkovics, JosephCytolytic immune lymphocytesJoseph G. SinkovicsJoseph (József) Géza Sinkovics was born in Budapest Hungary. After grammar school (1930-1934), he completed his high school education at Zrínyi Miklós Realgymnasium, Budapest (1934-1942). His mother enrolled him at the Medical Faculty of Pázmány Péter University and the residence, Collegium Medicum, Budapest, Hungary, in 1942. Attended one semester in Breslau and Halle an der Saale, Germany, in 1944-5. Served his internship at Rókus Hospital, Budapest; Szent Kereszt Hospital, Kalocsa; and Department of Neurology, University of Szeged, Hungary (1946-8). Received his Doctor of Medicine degree summa cum laude at Pázmány Péter University (now Semmelweis University) in 1948. He served as instructor at the Institute of Pathophysiology (1944; 1946-1948), and became assistant and adjunct professor at the Institute of Microbiology (Bacteriology & Immunology) at the University in Budapest (1948-1950). He was imprisoned and serv
ed as a physician at the tuberculosis wards of the ÁVH (State Security Police) Prison Hospital at Vác, at the Punitive Institution of State Security, until he was released and acquitted with "no crime committed" (1950-1954). He worked as senior virologist at the State Institute of Public Health, Budapest (1954-1956). He left Hungary in 1956. In the USA, he received a Rockefeller Fellowship at the Waksman Institute, Rutgers, The State University, New Brunswick, NJ (1957). He served as intern and resident physician at Cook County Hospital, Chicago, IL, and at the University of Texas M.D.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
